Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy

Journal of Medicinal Chemistry

Volumn 52, Issue 23, 2009, Pages 7829-7835

  Altieri, S ^a,b   Balzi, M ^c   Bortolussi, S ^a,b   Bruschi, P ^a   Ciani, L ^c   Clerici, A M ^a   Faraoni, P ^c   Ferrari, C ^a   Gadan, M A ^a,d   Panza, L ^e   Pietrangeli, D ^f   Ricciardi, G ^f   Ristori, S ^c  

^a UNIVERSITY OF PAVIA   (Italy)

^b INFN SEZIONE DI PAVIA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d DEPARTAMENTO DE FÍSICA   (Argentina)

^e UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^f UNIVERSITY OF BASILICATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 2 CLOSOCARBORANYL 2 HEXYLTHIOPORPHYRAZINE; 2 CLOSOCARBORANYL BETA LACTOSIDE; BORON; BORON DERIVATIVE; BOROPHENYLALANINE; CARBORANE DERIVATIVE; CATION; DRUG CARRIER; LIPOSOME; PHENYLALANINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; COLON CARCINOMA; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SYNTHESIS; LIVER METASTASIS; LUNG METASTASIS; MELANOMA; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN; RAT; SPECTROMETRY; SURFACE CHARGE;

ALPHA PARTICLES; ANIMALS; BIOLOGICAL TRANSPORT; BORANES; BORON; BORON NEUTRON CAPTURE THERAPY; CARBON; CELL LINE, TUMOR; DRUG CARRIERS; GLYCOSIDES; ISOTOPES; LIPOSOMES; MICE; RATS; SPECTRUM ANALYSIS;

EID: 72249092927     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm900763b     Document Type: Article

References (36)

1. Barth, R. F.; Coderre, J. A.; Vicente, M. G. H.; Blue, T. E. Boron neutron capture therapy of cancer: current status and future prospects. Clin. Cancer Res. 2005, 11, 3987-4002.
2. Busse, P.; Harling, O. K.; Palmer, M. R.; Kiger, W. S.; Kaplan, J.; Kaplan, I.; Chuang, C.; Goorley, J. Y.; Riley, K.; Newton, T. H.; Santa Cruz, G. A.; Lu, X.-Q.; Zamenhof, R. G. A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial on neutron capture therapy for intracranial disease. J. Neuro-Oncol. 2003, 62, 111-121. (Pubitemid 36553121)
3. Joensuu, H.; Kankaanranta, L.; Seppala, T.; Auterinen, I.; Kallio, M.; Kulvik, M.; Laakso, J.; Vaha talo, J.; Kortesniemi, M.; Kotiluoto, P.; Seren, T.; Karila, J.; Brander, A.; Jarviluoma, E.; Ryynanen, P.; Paetau, A.; Ruokonen, I.; Minn, H.; Tenhunen, M.; Jaaskelainen, J.; Farkkila, M.; Savolainen, S. Boron neutron capture therapy of brain tumours: clinical trials at the Finnish facility using borophenylalanine. J. Neuro-Oncol. 2003, 62, 123-134.
4. Nakagawa, Y.; Pooh, K.; Kobayashi, T.; Kageji, T.; Uyama, S.; Matsumura, A.; Kumada, H. Clinical review of the Japanese experience with boron neutron capture therapy and a proposed strategy using epithermal neutron beams. J. Neuro-Oncol. 2003, 62, 87-99. (Pubitemid 36553119)
5. Gonzales, S. J.; Bonomi, M. R.; Santa Cruz; Blaumann, G. A.; Calzetta Larrieu, O. A.; Menendez, P.; Jimenez Rebagliati, R.; Longhino, J.; Feld, D. B.; Dagrosa, M. A.; Angerich, C.; Castiglia, S. G.; Batistoni, D. A.; Libermann, S. J.; Roth, B. M. First BNCT treatment of a skin melanoma in Argentina: dosimetric analysis and clinical outcome. Appl. Radiat. Isot. 2004, 61, 1101-1105.
6. Kankaanranta, L.; Seppala, T.; Koivunoro, H.; Saarhilati, K.; Atula, T.; Collan, J.; Salli, E.; Kortesniemi, M.; Uusi-Simola, J.; Makitie, A.; Seppanen, M.; Minn, H.; Kotiluoto, H.; Auterinen, I.; Savolainen, S.; Kouri, M.; Joensuu, H. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer. Int. J. Radiat. Oncol., Biol., Phys. 2007, 69, 475-482.
7. Katoa, I.; Ono, K.; Sakurai, Y.; Ohmae, M.; Maruhashi, A.; Imahori, Y.; Kirihata, M.; Nakazawa, M.; Yura, Y. Effectiveness of BNCT for recurrent head and neck malignancies. Appl. Radiat. Isot. 2004, 61, 1069-1073.
8. Suzuki, M.; Sakuray, Y.; Masunaga, S.; Kinashi, Y.; Nagata, K.; Maruhashi, A.; Ono, K. Feasibility of boron neutron capture therapy (BNCT) for malignant pleural mesothelioma from a viewpoint of dose distribution analysis. Int. J. Radiat. Oncol., Biol., Phys. 2006, 66, 1584-1589.
9. Zonta, A.; Prati, U.; Roveda, L.; Ferrari, C.; Zonta, S.; Clerici, A. M.; Zonta, C.; Bruschi, P.; Nano, R.; Barni, S.; Pinelli, T.; Fossati, F.; Altieri, S.; Bortolussi, S.; Chiari, P.; Mazzini, G. Clinical lessons from the first applications of BNCT on unresectable liver metastases. J. Phys.: Conf. Ser. 2006, 41, 484-495.
10. Zonta, A.; Pinelli, T.; Prati, U.; Roveda, L.; Ferrari, C.; Clerici, A. M.; Zonta, C.; Mazzini, G.; Dionigi, P.; Altieri, S.; Bortolussi, S.; Bruschi, P.; Fossati, F. Extra-corporeal liver BNCT for the treatment of diffuse metastases: What was learned and what is still to be learned. Appl. Radiat. Isot. 2009, 67 (7-8, Suppl. 1), S67-S75.
11. Soloway, A. H.; Tjarks, W.; Barnum, B. A.; Rong, F. G.; Barth, R. F.; Codogni, I. M.; Gerald Wilson, J. The chemistry of neutron cature therapy. Chem. Rev. 1998, 98, 1515-1562.
12. Coderre, J. A.; Bergland, R.; Chada, M.; Chamana, A. D.; Elowitz, E.; Joel, D. D.; Liu, H. B.; Slatkin, D. N.; Wielopolski, L. Boron Neutron Capture Therapy of Glioblastoma Multiforme Using the p-Borophenylalanine-Fructose Complex and Epithermal Neutrons. In Neutron Capture Therapy for Cancer; Mishima, Y., Ed.; Plenum Press: New York, 1996; pp 553-561.
13. Hideghéty, K.; Sauerwein, W.; Wittig1, A.; Götz, C.; Paquis, P.; Grochulla, F.; Haselsberger, K.; Wolbers, J.; Moss, R.; Huiskamp, R.; Fankhauser, H.; de Vries, M.; Gabel, D. Tissue uptake of BSH in patients with glioblastoma in the EORTC 11961 phase I BNCT trial. J. Neuro-Oncol. 2003, 62, 145-156. (Pubitemid 36553124)
14. Roveda, L.; Prati, U.; Bakeine, J.; Trotta, F.;Marotta, P.; Valsecchi, P.; Zonta, A.;Nano,R.; Facoetti,A.; Chiari, P.; Barni, S.; Pinelli, T.; Altieri, S.; Braghieri, A.;Bruschi, P.; Fossati, F.; Pedroni, P.How to study boron biodistribution in liver metastases from colorectal cancer. J. Chemother. 2004, 16 (Suppl. 5), 15-18.
15. Fujii, S.; Goto, T.; Ohta, K.; Hashimoto, Y.; Suzuki, T.; Ohta, S.; Endo, Y. Potent androgen antagonists based on carborane as a hydrophobic core structure. J. Med. Chem. 2005, 48, 4654-4662.
16. Sivaev, I. B.; Bregadze, V. V. Polyhedral boranes for medical applications: current status and perspectives. Eur. Inorg. Chem. 2009, 11, 1433-1450.
17. Feakes, D. A.; Shelly, K.; Hawthorne, M. F. Selective boron delivery to murine tumors by lipophilic species incorporated in the membranes of unilamellar liposomes. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 1367-1370.
18. Peacock, G. F.; Ji, B.; Wang, C. K.; Lu, D. R. Cell culture studies of a carborane cholesteryl ester with conventional and PEG liposomes. Drug Delivery 2003, 10, 29-34.
19. Miyajima, Y.; Nakamura, H.; Kuwata, Y.; Lee, J. D.; Masunaga, S. M.; Ono, K.; Maruyama, K. Transferrin-loaded nido-carborane liposomes: tumor-targeting boron delivery system for neutron capture therapy. Bioconjugate Chem. 2006, 17, 1314-1320. (Pubitemid 44455341)
20. Mok, K. W.; Cullis, P. R. Structural and fusogenic properties of cationic liposomes in the presence of plasmid DNA. Biophys. J. 1997, 73, 2534-2545.
21. Ferrari, C.; Clerici, A. M.; Zonta, C.; Cansolino, L.; Boninella, A.; Altieri, S.; Ballarini, F.; Bortolussi, S.; Bruschi, P.; Stella, S.; Bakeine, J.; Dionigi, P.; Zonta, A. Boron Neutron Capture Therapy of Liver and Lung Coloncarcinoma Metastases: An in Vitro Survival Study. In A New Option against Cancer, Proceedings of the 13th International Congress on Neutron Capture Therapy, Florence, Italy; Zonta, A., Altieri, S., Roveda, L., Barth, R., Eds.; International Society for Neutron Capture Therapy, 2008; pp 331-336.
22. 10B compounds. Lancet 1989, 12, 388-389.
23. Becciolini, A.; Balzi, M.; Porciani, S.; Faraoni, P. Growth of Human Tumour and the Use of BNCT. In Proceedings of the Workshop on Experiments Relating to the Treatment of Tumors with Protons; de Boer, J., Becciolini, A., Eds.; Villa Vigoni: Como, Italy, 1999; pp 31-37.
24. Calorini, L.; Mannini, A.; Bianchini, F.; Mugnai, G.; Balzi, M.; Becciolini, A.; Ruggeri, S. Biological properties associated with the enhanced lung-colonizing potential in a B16 murine melanoma line grown in a medium conditioned by syngeneic Corynebacterium parvum-elicited macrophages. Clin. Exp. Metastasis 1999, 17, 889-895.
25. Cevc, G. Electrostatic characterization of liposomes. Chem. Phys. Lipids 1993, 64, 163-186.
26. Jones, M. N. The surface properties of phospholipid liposomes systems and their characterization. Adv. Colloid Interface Sci. 1995, 54, 93-128.
27. Giovenzana, G. B.; Lay, L.; Monti, D.; Palmisano, G.; Panza, L. Synthesis of carboranyl derivatives of alkynyl glycosides as potential BNCT agents. Tetrahedron 1999, 55, 14123-14136.
28. Ristori, S.; Salvati, A.; Martini, G.; Spalla, O.; Pietrangeli, D.; Rosa, A.; Ricciardi, G. Synthesis and liposome insertion of a new poly-carboranylalkylthio-porphyrazine to increase potentiality in multiple approach cancer therapy. J. Am. Chem. Soc. 2007, 129, 2728-2729.
29. Pietrangeli, D.; Ricciardi, G. Neutral and polyanionic carboranylporphyrazines: synthesis and physico-chemical properties. Appl. Radiat. Isot. 2009, 67, S97-S100.
30. Ristori, S.; Oberdisse, J.; Grillo, I.; Donati, A.; Spalla, O. Structural characterisation of cationic liposomes loaded with sugar-based carboranes. Biophys. J. 2005, 88, 535-547. (Pubitemid 40070699)
31. Salvati, A.; Ristori, S.; Pietrangeli, D.; Oberdisse, J.; Calamai, L.; Martini, G.; Ricciardi, G. Liposome insertion of a newly synthesized magnesium(II)-octacarboranyl(hexylsulfanyl) porphyrazine. Biophys. Chem. 2007, 131, 43-51.
32. Salvati, A.; Ristori, S.; Oberdisse, J.; Spalla, O.; Ricciardi, G.; Pietrangeli, D.; Giustini,M.;Martini, G. Small angle scattering and zeta potential of liposomes loaded with octa(carboranyl)porphyrazine. J. Phys. Chem. B 2007, 111, 10357-10364.
33. Ciani, L.; Ristori, S.; Salvati, A.; Calamai, L.; Martini, G. DOTAP/DOPE and DC-Chol/DOPE lipoplexes for gene delivery: zeta potential measurements and electron spin resonance spectra. Biochim. Biophys. Acta 2004, 1664, 70-79.
34. Martin, M. S.; Bastien, H.; Martin, F.; Michiels, R.; Martin, M. R.; Justrabo, E. Transplantation of intestinal carcinoma in inbred rats. Biomedicine 1973, 12, 555-558.
35. Martin, F.; Caignard, A.; Jeannin, J. F.; Leclerc, A.; Martin, M. Selection by trypsin of two sublines of rat colon cancer cells forming progressive or regressive tumors. Int. J. Cancer. 1983, 32, 623-627.
36. Chen, T. In situ detection of Mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp. Cell Res. 1977, 104, 255-262.